Pancreatic Cancer Research

ResearcherUniversidade de São PauloActive in the last 2 years

Sandro Mascena Gomes-Filho

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5069302207. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. LncRNA LINC00941 Links Oncogenic KRAS Signaling to Aggressiveness and Chemoresistance in Pancreatic Cancer Co-author DOI 10.1101/2025.09.29.679231↗
  2. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer. Co-author DOI 10.1007/s13402-020-00498-5↗
  3. Preparation, characterization and in vitro evaluation of ε-polylysine-loaded polymer blend microparticles for potential pancreatic cancer therapy. Co-author DOI 10.1080/02652048.2017.1370028↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniela S. Daniela Sanchez Bassères · 3 shared papers, 2017–2025 · strength 0.42
  2. Eduardo M. R. Reis · 2 shared papers, 2020–2025 · strength 0.34
  3. Thalita Bueno Corrêa · 1 shared paper, 2025 · strength 0.23
  4. Merari Tumin Chevalier · 1 shared paper, 2017 · strength 0.08
  5. Vera A. Álvarez · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.